Elliott Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,500,338
Closed -$247M 21
2025
Q1
$247M Hold
3,500,338
1.63% 6
2024
Q4
$230M Hold
3,500,338
1.38% 8
2024
Q3
$246M Hold
3,500,338
1.27% 8
2024
Q2
$288M Hold
3,500,338
1.66% 7
2024
Q1
$306M Buy
3,500,338
+500,000
+17% +$43.7M 1.9% 6
2023
Q4
$289M Buy
+3,000,338
New +$289M 1.55% 9